Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Barring any unforeseen circumstances, the Agreement will not have any effect on the issued and paid-up share capital of the Company. However, subject to Zhifei’s COVID-19 Vaccine being approved for commercialisation by the Government, the Agreement is expected to contribute positively to the future earnings and net assets per share of the Company.